Infectious Diseases (except HIV/AIDS)

COVER-ME: Developing and Evaluating community-based interventions to promote vaccine uptake in East London minority ethnicity (ME) populations; underserved migrants and persons with low income: protocol for a pilot randomised controlled trial
T. Chaudhry, P. Tum, Z H. Tam, A. Brentnall, H. Smethurst, K Kielmann, H. Kunst, S. Hargreaves, N J C. Campbell, C Griffiths, D Zenner

medRxiv 2024.08.21.24312371; doi: https://doi.org/10.1101/2024.08.21.24312371

Add to Selected Citations
Detection of novel Plasmodium falciparum haplotypes under treatment pressure in pediatric severe malaria
Balotin Fogang, Emilie Guillochon, Claire Kamaliddin, Gino Agbota, Sem Ezinmegnon, Maroufou Jules Alao, Philippe Deloron, Gwladys Bertin, Antoine Claessens

medRxiv 2024.08.20.24312296; doi: https://doi.org/10.1101/2024.08.20.24312296

Add to Selected Citations
Respiratory virus detection and sequencing from negative SARS-CoV-2 rapid antigen tests
Emmanuela Jules, Charlie Decker, Brianna Jeanne Bixler, Alaa Ahmed, Zijing (Carol) Zhou, Itika Arora, Henok Tafesse, Hannah Dakanay, Andrei Bombin, Ethan Wang, Jessica Ingersoll, Kathy Bifulco, Jennifer K. Frediani, Richard Parsons, Julie Sullivan, Morgan Greenleaf, Jesse J. Waggoner, Greg S. Martin, Wilbur A. Lam, Anne Piantadosi

medRxiv 2024.08.19.24311993; doi: https://doi.org/10.1101/2024.08.19.24311993

Add to Selected Citations
Marked heterogeneity in malaria infection risk in a Malian longitudinal cohort
Emily LaVerriere, Zachary M. Johnson, Meg Shieh, Nadege Nziza, Galit Alter, Caroline O. Buckee, Peter D. Crompton, Boubacar Traore, Tuan M. Tran, Daniel E. Neafsey

medRxiv 2024.08.20.24312307; doi: https://doi.org/10.1101/2024.08.20.24312307

Add to Selected Citations
Cost-Effectiveness of Vaccination Strategies to Control Future Mpox Outbreaks in England
Xu-Sheng Zhang, Siwaporn Niyomsri, Sema Mandal, Hamish Mohammed, Miranda Mindlin, Bennet Dugbazah, Solomon Adjei, Andre Charlett, Jessica Edney, Elliot Sugars, Merav Kliner, Trish Mannes, Ellie Jewitt, Lorna Gilbert, Samihah Moazam, Claire Dewsnap, David Phillips, Gayatri Amirthalingam, Mary E. Ramsay, Peter Vickerman, Josephine Walker

medRxiv 2024.08.20.24312301; doi: https://doi.org/10.1101/2024.08.20.24312301

Add to Selected Citations
Pulmonary FABP4 is an inverse biomarker of pneumonia in critically ill children and adults
Emily C. Lydon, Hoang Van Phan, Eran Mick, Natasha Spottiswoode, Carolyn S. Calfee, Peter M. Mourani, Charles R. Langelier

medRxiv 2024.08.19.24312242; doi: https://doi.org/10.1101/2024.08.19.24312242

Add to Selected Citations
Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States
Sang Woo Park, Brooklyn Noble, Emily Howerton, Bjarke F Nielsen, Sarah S Jiudice, Lilliam Ambroggio, Samuel Dominguez, Kevin Messacar, Bryan T Grenfell

medRxiv 2024.08.19.24312254; doi: https://doi.org/10.1101/2024.08.19.24312254

Add to Selected Citations
Seroepidemiology of human leptospirosis in the Dominican Republic: a multistage cluster survey, 2021
Eric J. Nilles, Cecilia Then Paulino, Renee Galloway, Michael de St. Aubin, Helen J. Mayfield, Angela Cadavid Restrepo, Devan Dumas, Salome Garnier, Marie Caroline Etienne, William Duke, Farah Peña, Naomi Iihoshi, Gabriela Abdalla, Beatriz Lopez, Lucia de la Cruz, Bernarda Henríquez, Kara Durski, Margaret Baldwin, Gideon Loevinsohn, Eleanor M. Rees, Beatris Martin, Benn Sartorius, Ronald Skewes-Ramm, Emily Zielinski Gutiérrez, Adam Kucharski, Colleen L. Lau

medRxiv 2024.08.19.24312221; doi: https://doi.org/10.1101/2024.08.19.24312221

Add to Selected Citations
Percent of lung involved in disease on chest X-ray predicts unfavorable treatment outcome in pulmonary tuberculosis
Marwan Ghanem, Ratnam Srivastava, Yasha Ektefaie, Drew Hoppes, Gabriel Rosenfeld, Ziv Yaniv, Alina Grinev, Ava Y. Xu, Eunsol Yang, Gustavo E. Velásquez, Linda Harrison, Alex Rosenthal, Radojka M. Savic, Karen R. Jacobson, Maha R. Farhat

medRxiv 2024.08.19.24311411; doi: https://doi.org/10.1101/2024.08.19.24311411

Add to Selected Citations
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2024 vaccines in the United Kingdom
Michele A. Kohli, Michael Maschio, Amy Lee, Keya Joshi, Stuart Carroll, Orsolya Balogh, Nicholas van de Velde, Ekkehard Beck

medRxiv 2024.08.19.24312243; doi: https://doi.org/10.1101/2024.08.19.24312243

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages